TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds December 3, 1999